Your cart is empty
Browse supplements to get started.
In the first human brain imaging study of its kind, researchers found that Selank (anxiolytic) and Semax (nootropic) produce measurable changes in functional connectivity between the amygdala and temporal cortex regions within 5-20 minutes of administration, with each peptide showing both shared and unique connectivity patterns.
This study provides the first objective brain imaging evidence that Selank and Semax work through distinct neurological pathways in humans, not just subjective reporting. The rapid onset of connectivity changes (visible within 5 minutes) helps explain why users often report quick cognitive and mood effects, and suggests these peptides may be useful tools for targeted modulation of specific brain networks rather than general cognitive enhancement.
While Selank and Semax have been studied for decades in Russian research, Western neuroscience has lacked rigorous functional imaging data on their mechanisms. This connectomic approach represents a significant methodological advance, using resting-state fMRI to map whole-brain effects rather than focusing on isolated brain regions. The amygdala-temporal cortex connectivity changes are particularly relevant given these regions' roles in emotional regulation and memory processing.
Functional Connectomic Approach to Studying Selank and Semax Effects.
This is an educational summary of published research, not medical advice. Always consult a healthcare provider before starting any peptide protocol.
